ExcellGene is a swiss pharmaceutical contract development and manufacturing organization (CDMO). The company applies smart science and innovative cell line development and process optimization technologies to provide high-quality pharmaceutical proteins from CHO and HEK
With over 20 years of experience, ExcellGene specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus).
